Immunoprecise Antibodies shares owned by Ingalls & Snyder
Quarter-by-quarter ownership of Immunoprecise Antibodies (IPA) shares owned by Ingalls & Snyder
from 13F filings
Historical chart of Ingalls & Snyder investment in Immunoprecise Antibodies
Tip: Access up to 7 years of quarterly data
All positions including Immunoprecise Antibodies held by Ingalls & Snyder consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunoprecise Antibodies by Ingalls & Snyder
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $996k | 1.6M | 0.64 |
| 2024-06-30 | $1.3M | 1.3M | 1.01 |
| 2024-03-31 | $2.0M | 1.3M | 1.52 |
| 2023-12-31 | $2.2M | 1.3M | 1.71 |
| 2023-09-30 | $1.9M | 1.0M | 1.83 |
| 2023-06-30 | $3.1M | 1.1M | 2.96 |
| 2023-03-31 | $2.9M | 1.1M | 2.77 |
| 2022-12-31 | $5.1M | 970k | 5.21 |
| 2022-09-30 | $3.9M | 967k | 3.99 |
| 2022-06-30 | $3.6M | 940k | 3.80 |
| 2022-03-31 | $4.8M | 932k | 5.14 |
| 2021-12-31 | $4.4M | 820k | 5.36 |
| 2021-09-30 | $3.9M | 621k | 6.22 |
| 2021-06-30 | $3.6M | 601k | 6.02 |
| 2021-03-31 | $5.1M | 517k | 9.82 |
| 2020-12-31 | $5.9M | 396k | 14.95 |